Effects of Satureja Khuzestanica Jamzad on type 2 diabetes

????? ???????:Effects of Satureja Khuzestanica Jamzad supplementation on blood glucose control, serum insulin,lipid profile, and liver function in type 2 diabetes patients: a randomized controlled clinical trial study (RCT)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190715044214N1

Enrollment

Registered

2021-02-21

Start date

2021-02-19

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: The subjects in the intervention group will be given a capsule containing 500 mg of Satureja Khuzestanica. They should take a 500 mg capsule daily for 12 weeks. Int

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age between 20 and 65 years BMI between 18.5 and 35 Willingness to cooperate Completing the informed consent form

Exclusion criteria

Exclusion criteria: Insulin therapy Pregnancy Lactation Allergy to Satureja Khuzestanica Being on weight loss diet

Design outcomes

Primary

Measure	Time frame
FBS. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;TG. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;LDL-c. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;AST. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.	—

Measure

Time frame

FBS. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;TG. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;LDL-c. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.;AST. Timepoint: Before and 12 weeks after beginning intervention. Method of measurement: Serum levels Measuring.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSajjad Roosta

Khoram-Abad University of Medical Sciences

sajjad.roosta@yahoo.com+98 66 3342 1216

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026